Spolana Neratovice, the producer of drugs and chemicals in Neratovice in the central Bohemia region of the Czech Republic, recorded gross profit for 1994 of 350 million koruna ($13.1 million), according to the CTK news agency's Business News. First quarter 1995 exports amounted to 97 million koruna.
- Rhone-Poulenc, the French drugs and chemicals group, achieved turnover of 850 million koruna ($31.6 million) in the Czech Republic for 1994, the news agency reports. Sales for the current year are expected to increase to 1 billion koruna.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze